Literature DB >> 32644244

Automated office blood pressure is in agreement with awake and mean 24-hour ambulatory blood pressure at the lower blood pressure range.

Emmanuel A Andreadis1, Charalampia V Geladari1, Epameinondas T Angelopoulos1.   

Abstract

Automated office blood pressure measurement eliminates the white coat effect and is associated with awake ambulatory blood pressure. This study examined whether automated office blood pressure values at lower limits were comparable to those of awake and mean 24-hour ambulatory blood pressure. A total of 552 patients were included in the study, involving 293 (53.1%) men and 259 (46.9%) women, with a mean age 55.0 ± 12.5, of whom 36% were treated for hypertension. Both systolic and diastolic automated office blood pressures exhibited lower values compared to awake ambulatory blood pressure among 254 individuals with systolic automated office blood pressure <130 mm Hg (119 ± 8 mm Hg vs 125 ± 11 mm Hg, P < .0001 and 75 ± 9 mm Hg vs 79 ± 9 mm Hg, P < .0001 for systolic and diastolic BPs, respectively). Furthermore, the comparison of systolic automated office blood pressure to the mean 24-hour ambulatory blood pressure levels also showed lower values (119 ± 8 vs 121 ± 10, P = .007), whereas the diastolic automated office blood pressure measurements were similar to 24-hour ambulatory blood pressure values. Our findings show that when automated office blood pressure readings express values <130/80 mm Hg in repeated office visits, further investigation should be performed only when masked hypertension is suspected; otherwise, higher automated office blood pressure values could be used for the diagnosis of uncontrolled hypertension, especially in individuals with organ damage.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  agreement; automated office blood pressure; cutoff values; hypertension; mean ambulatory blood pressure values

Mesh:

Year:  2020        PMID: 32644244      PMCID: PMC8029795          DOI: 10.1111/jch.13927

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  19 in total

1.  Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the International Protocol.

Authors:  George S Stergiou; Periklis P Giovas; Charilaos P Gkinos; John D Patouras
Journal:  Blood Press Monit       Date:  2007-06       Impact factor: 1.444

2.  SPRINT Blood Pressure: Sprinting Back to Smirk's Basal Blood Pressure?

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Grzegorz Bilo; Alberto Zanchetti
Journal:  Hypertension       Date:  2016-11-14       Impact factor: 10.190

3.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

Review 4.  Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association.

Authors:  Paul Muntner; Daichi Shimbo; Robert M Carey; Jeanne B Charleston; Trudy Gaillard; Sanjay Misra; Martin G Myers; Gbenga Ogedegbe; Joseph E Schwartz; Raymond R Townsend; Elaine M Urbina; Anthony J Viera; William B White; Jackson T Wright
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

5.  Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial.

Authors:  O R Benavente; C S Coffey; R Conwit; R G Hart; L A McClure; L A Pearce; P E Pergola; J M Szychowski
Journal:  Lancet       Date:  2013-05-29       Impact factor: 79.321

6.  Office blood pressure is lower than awake ambulatory blood pressure at lower targets for treatment.

Authors:  Martin G Myers; Janusz Kaczorowski
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-24       Impact factor: 3.738

7.  Comparison of awake ambulatory blood pressure and automated office blood pressure using linear regression analysis in untreated patients in routine clinical practice.

Authors:  Martin G Myers; Murray Matangi; Janusz Kaczorowski
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-16       Impact factor: 3.738

8.  Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial.

Authors:  Martin G Myers; Marshall Godwin; Martin Dawes; Alexander Kiss; Sheldon W Tobe; F Curry Grant; Janusz Kaczorowski
Journal:  BMJ       Date:  2011-02-07

Review 9.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

10.  Automated office blood pressure measurements obtained with and without preceding rest are associated with awake ambulatory blood pressure.

Authors:  Emmanuel A Andreadis; Charalampia V Geladari; Epameinondas T Angelopoulos
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-01       Impact factor: 3.738

View more
  1 in total

1.  Automated office blood pressure is in agreement with awake and mean 24-hour ambulatory blood pressure at the lower blood pressure range.

Authors:  Emmanuel A Andreadis; Charalampia V Geladari; Epameinondas T Angelopoulos
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-09       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.